Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022 10:52 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
January 12, 2022 09:56 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF),a comprehensive medical diagnostics and related solutions company,...
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
January 10, 2022 14:06 ET
|
Todos Medical Ltd.
“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and Tel Aviv, ISRAEL, Jan. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd....
Todos Medical CEO Provides Letter to Shareholders
January 05, 2022 18:04 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
January 03, 2022 08:30 ET
|
Todos Medical Ltd.
NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
December 27, 2021 09:01 ET
|
Todos Medical Ltd.
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster shot durability emerge The Company also entered into a...
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
December 23, 2021 07:37 ET
|
Todos Medical Ltd.
CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss the authorization of Pfizer’s COVID antiviral drug & Tollovir™ Phase 2 for hospitalized COVID New York, NY,...
Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States
December 22, 2021 09:56 ET
|
Todos Medical Ltd.
§ Provista completed validation for fingerprick At-Home sample collection of blood for the cPass neutralizing antibody test New York, NY, and Tel Aviv, ISRAEL, Dec. 22, 2021 (GLOBE NEWSWIRE)...
Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing
December 20, 2021 07:30 ET
|
Todos Medical Ltd.
Company retains iiiNTENT SAAS artificial intelligence marketing service for Tollovid® and Tollovid Daily™ 3CL protease inhibitor dietary supplement products NEW YORK, NY and TEL AVIV, Israel , Dec....
Todos Medical Announces “Test & Tollovid®” Holiday Package for Atlanta Area at Provista Diagnostics
December 17, 2021 08:51 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...